Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial.
Hakeem A, Shah JA, Kumar R, Ali A, Lakho AA, Zeeshan H, Uddin MI, Khan K, Solangi B, Kumar M, Kumar M, Awan R, Ishaq H, Farooq F, Haq EU, Hameed A, Lehri WA, Zada S, Ali A, Raza A, Masood S, Humza A, Karim M; TADCLOT Investigators.
Hakeem A, et al.
J Am Coll Cardiol. 2025 Dec 9;86(23):2330-2345. doi: 10.1016/j.jacc.2025.08.041. Epub 2025 Aug 30.
J Am Coll Cardiol. 2025.
PMID: 40892606
Clinical Trial.